Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Structural Heart Market Grown from 2024 to 2025?
The size of the structural heart market has seen a solid growth lately. The market, which stands at $14.9 billion in 2024, is projected to expand to $15.99 billion by 2025, with a compound annual growth rate (CAGR) of 7.3%. The surge in growth during the historic phase can be credited to heightened awareness and screening, robust supply chain resilience, a rise in health care spending, market concentration, and a growing consciousness about cardiovascular diseases.
What Growth Rate Is Anticipated for the Structural Heart Market in the Coming Years?
The size of the structural heart market is projected to experience significant expansion over the forthcoming years, with expectations to reach $22.43 billion by the year 2029, encapsulating a compound annual growth rate (CAGR) of 8.8%. Factors contributing to the expansion during the forecast period encompass an escalating demand for heart valve devices, an increasingly aged population, the growing prevalence of cardiovascular conditions, market partitioning, and growth in regional markets. Key trends identified during the forecast period include the introduction of new products, advancements in technology, economic resurgence, regulatory mandates, a surge in cardiovascular disease instances, and the innovation of medical devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12029&type=smp
Who Are the Leading Companies in the Structural Heart Market?
Major companies operating in the structural heart market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Trane Technologies, Lepu Medical Technology Co. Ltd., LivaNova PLC, Biomerics LLC, Venus Medtech (Hangzhou) Inc., Cryolife Inc., Endologix Inc., Shockwave Medica Inc., Braile Biomédica, JenaValve Technology Inc., Corvia Medical Inc, HLT Medical, On-X Life Technologies Inc., Symetis SA, Magenta Therapeutics, PASCAL Medical, Micro Interventional Devices Inc., CardioKinetix Inc, Tendyne Holdings Inc., Q’Apel Medical Inc., Neovasc Inc., NVT AG, Z-Medical GmbH + Co. KG
What Are the Key Drivers of the Structural Heart Market?
The escalating cases of cardiovascular maladies are anticipated to drive the expansion of the structural heart market. Cardiovascular conditions, which affect the heart and blood vessels and include diseases like coronary artery disease, heart failure, and stroke, are primarily increasing due to factors like an aging population, lifestyle and dietary changes, and a growth in obesity and diabetes rates. Devices and services for the structural heart provide diagnosis and treatment for disorders impacting the valves, chambers, and surrounding structures of the heart. These treatments are minimally invasive, providing a more efficient solution with fewer risks compared to open-heart surgery. As an illustration, a report by the American College of Cardiology in August 2022 predicted that all four cardiovascular risk factors in the United States would see a rise between 2025 and 2060. The most significant rise is expected in diabetes, increasing by 39.3% to 55 million people, followed by dyslipidemia (increasing by 27.6% to 126 million), hypertension (increasing by 25.1% to 162 million), and obesity (increasing by 18.3% to 126 million). The largest predicted surges in cardiovascular disease rates were identified in stroke (increasing by 33.8% to 15 million) and heart failure (increasing by 33.4% to 13 million), followed by ischemic heart disease (increasing by 30.7% to 29 million) and heart attack (increasing by 16.9% to 16 million). Consequently, the growing cases of cardiovascular conditions are catalyzing the expansion of the structural heart market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12029&type=smp
What Are the Key Market Segments in the Structural Heart Industry?
The structural heart market covered in this report is segmented –
1) By Product: Occluders, Annuloplasty Rings, Heart Valve Balloons, Other Products
2) By Procedure: Heart Valve Stenosis, Heart Valve Regurgitation, Left Atrial Appendage Closure
3) By End Users: Hospitals, Ambulatory Surgical Centers, Cardiac Centers
Subsegments:
1) By Occluders: Atrial Septal Defect (ASD) Occluders, Patent Foramen Ovale (PFO) Occluders, Ventricular Septal Defect (VSD) Occluders
2) By Annuloplasty Rings: Rigid Annuloplasty Rings, Flexible Annuloplasty Rings, Adjustable Annuloplasty Rings
3) By Heart Valve Balloons: Balloon Expandable Heart Valve Systems, Valvuloplasty Balloons
4) By Other Products: Transcatheter Heart Valves, Structural Heart Imaging Devices, Delivery Systems For Structural Heart Procedures
What Are the Latest Trends in the Structural Heart Market?
The rise in technological innovation is noted as a leading trend within the structural heart market, gaining significant attention. Larger market players in the structural heart sector are focusing on developing novel products to cement their market stance. Notably, in February 2023, Eko Health, a US-based digital health company, introduced the SENSORA platform aimed at detecting cardiac diseases in a non-invasive manner for primary care. The SENSORA platform employs artificial intelligence to precisely identify structural murmurs indicative of valvular heart disease and includes care pathway analytics software that offers insights and measurements for the patient’s passage through the healthcare system by recording and examining heart sounds and electrical signals via its digital stethoscopes. The platform is designed to assist in crucial decision-making by identifying potential care shortcomings that could be translated into increased operational efficiency, such as minimizing delays in care delivery, duration of stay, and readmission rates, whilst improving satisfaction for both patients and physicians.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report
What Are the Key Regional Markets in the Structural Heart Industry?
North America was the largest region in the structural heart market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12029
This Report Delivers Insight On:
1. How big is the structural heart market, and how is it changing globally?
2. Who are the major companies in the structural heart market, and how are they performing?
3. What are the key opportunities and risks in the structural heart market right now?
4. Which products or customer segments are growing the most in the structural heart market?
5. What factors are helping or slowing down the growth of the structural heart market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
